GSK Is Able to Supply Cervarix for Vaccination at Subjects’ Own Expense

October 3, 2011
GlaxoSmithKline K.K. (GSK) announced on September 30 that the company is able to Supply the cervical cancer preventative vaccine Cervarix from October 1 for vaccination at subjects’ own expense. Cervarix has been short in supply due to the initiation of...read more